Filing Details

Accession Number:
0000711377-19-000056
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-21 10:58:44
Reporting Period:
2019-11-19
Accepted Time:
2019-11-21 10:58:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-19 15,085 $60.43 202,055 No 4 M Direct
Common Stock Disposition 2019-11-19 15,085 $64.70 186,970 No 4 S Direct
Common Stock Acquisiton 2019-11-20 11,780 $60.43 198,750 No 4 M Direct
Common Stock Disposition 2019-11-20 11,780 $64.55 186,970 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2019-11-19 15,085 $0.00 15,085 $60.43
Common Stock Common Stock (Right to Buy) Disposition 2019-11-20 11,780 $0.00 11,780 $60.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
160,914 2022-11-27 No 4 M Direct
149,134 2022-11-27 No 4 M Direct
Footnotes
  1. The options were granted 10/27/2019, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant